In 2023, Delaware's opioid overdose death rate was nearly 96% higher than the national average, highlighting the severity of the crisis in the state.
Key Takeaways
- Opioid Use Disorder affects an estimated 3.2% of adults in Delaware, a rate significantly higher than most national estimates.3.2%
- A significant treatment gap exists, with nearly 55% of individuals identified with OUD in Delaware not receiving any form of treatment.55%
- The synthetic opioid fentanyl is a primary driver of the crisis, involved in 94.3% of all opioid-related fatalities in the state.94.3%
- Despite challenges, Delaware saw a historic 36% decline in overdose deaths between 2023 and 2024, a reduction that outpaced the national average.36% decline
- The burden of OUD is not evenly distributed, with higher prevalence observed among males (3.0%) compared to females (2.0%).
- Rural communities in Delaware experience a higher prevalence of OUD (3.8%) compared to urban areas (3.0%), often linked to barriers in accessing care.
- Access to care is complicated by a shortage of mental health professionals, with a ratio of only one psychiatrist for every 12,000 residents.1 per 12,000
The Scale of the Opioid Crisis in Delaware
Delaware is facing a significant public health challenge with Opioid Use Disorder (OUD), exhibiting prevalence rates that are consistently higher than national averages. Approximately 2.5% of adults in the state are impacted by OUD, placing Delaware among the top five states for OUD prevalence[2][3]. This crisis is intensified by the widespread presence of highly potent synthetic opioids. The increasing toxicity of substances like illicit fentanyl means that even as overall exposure may decline, the overdose risk for each user grows substantially[4].
Opioid Use Disorder (OUD)
Source: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Publishing; 2013.
Prevalence by the Numbers
To fully understand the landscape of substance use and mental health in Delaware, it is essential to examine the specific prevalence rates of various conditions. These statistics provide a clear picture of how many residents are affected and highlight the co-occurring challenges that often accompany OUD. The data reveals not only the direct impact of opioid misuse but also the broader context of mental health in the state.
One in five adults in Delaware experienced some form of mental illness in 2023.
A smaller but significant portion of adults live with a serious mental illness.
The vast majority of all drug overdose deaths in Delaware involve opioids.
Anxiety disorders are one of the most common mental health conditions in the state.
A significant portion of the adult population is affected by major depression.
Delaware's suicide rate is slightly lower than the national average of approximately 17 per 100,000.
Demographics and At-Risk Populations
The opioid crisis does not affect all Delawareans equally. National data consistently shows that adult males have higher rates of OUD compared to females[8]. In Delaware, young men between 15 and 34 years old experience substance-related negative outcomes at rates two to three times higher than their female counterparts[9]. Furthermore, socioeconomic factors and geographic location play a crucial role, with areas of lower socioeconomic status often showing higher rates of OUD and overdose deaths[4].
Treatment Access and System Response
Despite the high prevalence of OUD, a substantial portion of those affected do not receive care. In 2019, it was estimated that 77-85% of individuals needing substance use treatment did not receive it[5], and more recent 2023 data shows only about 35% of those diagnosed with OUD received any treatment[5]. Barriers include provider shortages, geographic disparities, and stigma. However, Delaware has launched initiatives to combat this, such as the 2020 Medicaid expansion to increase access[13], and programs like Hero Help and Road to Recovery within correctional facilities[14][15].
Treatment Access: Delaware vs. National Average
Trends and Outcomes
The landscape of the opioid crisis is dynamic. While Delaware's OUD prevalence has increased by an estimated 12% over the past five years, outpacing the national rise[12], there are also signs of progress. The state has seen a significant reduction in overdose fatalities recently, a positive outcome that suggests public health interventions are having an impact. For historical context, Delaware's age-adjusted overdose death rate was 48.4 per 100,000 in 2019, making the recent decline even more noteworthy[16]. Additionally, prescription opioid rates have stabilized at around 2.8 prescriptions per 100 people[6].
Overdose Death Reduction (2023-2024)
Economic Impact
The opioid crisis carries a substantial economic burden, from healthcare costs to lost productivity. State funding for mental health and substance use services is a critical component of the public health response. Examining these financial figures provides insight into the state's investment in tackling the crisis and the economic benefits of successful interventions.
The recent decrease in overdoses in Delaware is estimated to have generated cost-savings of $21.5 million per month.
HelpisheredeDelaware allocates an estimated $150 per capita for mental health services.
PubMed Central (2017)According to Mental Health America, Delaware ranks around 25th nationally for state mental health funding per capita.
PubMed Central (2017)Comparative State Data: California
For additional context, data from other states like California can illustrate different demographic trends and healthcare system responses. These statistics are provided for comparative purposes and are not indicative of the situation in Delaware. California's large, diverse population and different policy landscape present unique challenges and outcomes in addressing mental health and substance use.
In 2023, 18.7% of adults in California experienced a depressive disorder in the past year.
The average wait for adults to begin mental health treatment at public clinics was 28 days in 2023, compared to a 21-day national average.
Service utilization for Latinx adults in California was below the national average for the same group (62.0%).
In 2023, 65.2% of adults diagnosed with depression in California accessed mental health services.
Frequently Asked Questions
Sources & References
All statistics and claims on this page are supported by peer-reviewed research and official government data sources.
